Makefield Therapeutics Appoints Jim Ballance Chief Scientific Officer

NEWTOWN, Pa.--(BUSINESS WIRE)--Makefield Therapeutics, Inc., an emerging pharmaceutical company, today announced the appointment of Jim Ballance, Ph.D., as Chief Scientific Officer. Dr. Ballance, most recently a corporate strategic consultant to the biotechnology industry, is an experienced technology and corporate development professional whose career has included senior management positions at both large and small companies in the United States and United Kingdom.